We are live on ! Find out more
MLA

MB, Levis & Associates Portfolio holdings

AUM $240M
1-Year Est. Return 12.17%
This Fund
S&P 500
This Quarter Est. Return
-0.17%
1 Year Est. Return
+12.17%
3 Year Est. Return
+32.71%
5 Year Est. Return
10 Year Est. Return
AUM
$240M
AUM Growth
+$2.13M
Cap. Flow
+$4.23M
Cap. Flow %
1.76%
Top 10 Hldgs %
63.69%
Holding
256
New
11
Increased
72
Reduced
31
Closed
22

Top Sells

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$137K
2
KMI icon
Kinder Morgan
KMI
+$46.9K
3
MRK icon
Merck
MRK
+$36.8K
4
ADP icon
Automatic Data Processing
ADP
+$25.7K
5
NEE icon
NextEra Energy
NEE
+$22.8K

Sector Composition

Rank Sector Weight
1 Technology 5.21%
2 Industrials 4.87%
3 Healthcare 3.48%
4 Financials 2.88%
5 Consumer Staples 2.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMCSA icon
201
Comcast
CMCSA
$84.9B
$2.87K ﹤0.01%
100
KD icon
202
Kyndryl
KD
$2.69B
$2.56K ﹤0.01%
195
-15
-7% -$264
AZZ icon
203
AZZ Inc
AZZ
$4.43B
$2.5K ﹤0.01%
20
UPS icon
204
United Parcel Service
UPS
$96.2B
$2.46K ﹤0.01%
25
PWRD
205
TCW Transform Systems ETF
PWRD
$1.44B
$2.44K ﹤0.01%
25
-25
-50% -$2.55K
MICC
206
The Magnum Ice Cream Company N.V.
MICC
$11.4B
$2.42K ﹤0.01%
162
CI icon
207
Cigna
CI
$75.1B
$2.32K ﹤0.01%
9
WBD icon
208
Warner Bros
WBD
$64.8B
$2.28K ﹤0.01%
83
UA icon
209
Under Armour Class C
UA
$3.04B
$2.26K ﹤0.01%
390
DXCM icon
210
DexCom
DXCM
$29.2B
$2.01K ﹤0.01%
32
TWLO icon
211
Twilio
TWLO
$31.2B
$1.89K ﹤0.01%
15
PGNY icon
212
Progyny
PGNY
$2.49B
$1.7K ﹤0.01%
100
KHC icon
213
Kraft Heinz
KHC
$30.7B
$1.69K ﹤0.01%
75
VXUS icon
214
Vanguard Total International Stock ETF
VXUS
$152B
$1.6K ﹤0.01%
21
URNM icon
215
Sprott Uranium Miners ETF
URNM
$1.74B
$1.56K ﹤0.01%
25
FCX icon
216
Freeport-McMoran
FCX
$84.5B
$1.48K ﹤0.01%
25
PINS icon
217
Pinterest
PINS
$12.8B
$1.47K ﹤0.01%
80
PLTR icon
218
Palantir
PLTR
$323B
$1.46K ﹤0.01%
10
MOO icon
219
VanEck Agribusiness ETF
MOO
$976M
$1.32K ﹤0.01%
16
OGN icon
220
Organon & Co
OGN
$3.54B
$1.2K ﹤0.01%
201
+1
+0.5% +$8
CRON
221
Cronos Group
CRON
$1.05B
$828 ﹤0.01%
330
ORGN
222
DELISTED
Origin Materials
ORGN
$682 ﹤0.01%
299
+1
+0.3% +$5
VTRS icon
223
Viatris
VTRS
$19.8B
$654 ﹤0.01%
48
VYNE icon
224
VYNE Therapeutics
VYNE
$27M
$622 ﹤0.01%
1,041
KPTI icon
225
Karyopharm Therapeutics
KPTI
$169M
$557 ﹤0.01%
100

Similar funds

MB, Levis & Associates's Q1 2026 Portfolio in Review

As of Q1 2026, MB, Levis & Associates held 256 positions worth $240M, up 0.9% from $238M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

MB, Levis & Associates's Q1 2026 filing shows 11 new, 72 increased, 31 reduced and 22 closed positions. Its largest new stake was Essential Utilities: 951 shares worth $38.3K. The largest sale was AstraZeneca, an estimated $137K.

By sector, the portfolio is most concentrated in Technology at 5.2% of assets, down from 6.2% a quarter earlier, followed by Industrials and Healthcare.

  • MB, Levis & Associates's largest Q1 2026 buy was Essential Utilities: 951 shares worth $38.3K.
  • MB, Levis & Associates added most to T. Rowe Price Dividend Growth ETF in Q1 2026, an estimated $1.52M increase.
  • MB, Levis & Associates's biggest Q1 2026 reduction was Kinder Morgan, cutting an estimated $46.9K.
  • MB, Levis & Associates fully exited AstraZeneca in Q1 2026, selling an estimated $137K.
  • MB, Levis & Associates's ten largest holdings make up 64% of its $240M portfolio in Q1 2026.
  • MB, Levis & Associates opened 11 new positions and closed 22 in Q1 2026.
  • MB, Levis & Associates's portfolio value rose 0.9% quarter-over-quarter to $240M.

Based on MB, Levis & Associates's 13F filing for Q1 2026, filed 8 Apr 2026.